Kilitch Drugs has announced a rights issue of 13.98 lakh equity shares at an issue price of ₹357 per share (face value ₹10). The entitlement ratio is 2 shares for every 23 shares held. The record date for eligibility is July 15, 2025. The issue aims to raise approximately ₹50 Cr (13.98 lakh x ₹357) to strengthen the company’s capital base. Existing shareholders have the opportunity to increase their stake at a discounted price, which will slightly increase the total equity from about 1.61 Cr to 1.75 Cr shares if fully subscribed.